Is the risk of ovarian hyperstimulation syndrome adequately addressed in high anti-Müllerian hormone and PCOS patients undergoing IVF?

Ayushi Agarwal; Anjali Mundkur; Vidyashree G. Poojari; Prashanth Adiga; Pratap Kumar

doi:10.1016/j.rbmo.2025.105183

Is the risk of ovarian hyperstimulation syndrome adequately addressed in high anti-Müllerian hormone and PCOS patients undergoing IVF?

Ayushi Agarwal
, Anjali Mundkur^*
, Vidyashree G. Poojari
, Prashanth Adiga
, Pratap Kumar

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	105183
Journal	Reproductive BioMedicine Online
Volume	51
Issue number	4
DOIs	https://doi.org/10.1016/j.rbmo.2025.105183
Publication status	Published - 10-2025

All Science Journal Classification (ASJC) codes

Reproductive Medicine
Obstetrics and Gynaecology
Developmental Biology

Access to Document

10.1016/j.rbmo.2025.105183

Cite this

@article{3dc7757588714bb29c091deb5eed6195,

title = "Is the risk of ovarian hyperstimulation syndrome adequately addressed in high anti-M{\"u}llerian hormone and PCOS patients undergoing IVF?",

author = "Ayushi Agarwal and Anjali Mundkur and Poojari, \{Vidyashree G.\} and Prashanth Adiga and Pratap Kumar",

year = "2025",

month = oct,

doi = "10.1016/j.rbmo.2025.105183",

language = "English",

volume = "51",

journal = "Reproductive BioMedicine Online",

issn = "1472-6483",